: NUDT5 is indicative of poor prognosis and aggressive cancer growth. (A) NUDT5 mRNA expression across full TGCA database, data for tumour (red) and normal (green) tissue from the same tissue origin are shown using TGCA patient datasets with GEPIA interactive webserver [61]. Datasets where NUDT5 mRNA levels are elevated in tumour versus normal as highlighted in red, significantly higher in normal versus tumour are marked in green. Abbreviations of the tumour datasets are given in Table S1 . (B) The percentage of positive staining for NUDT5 protein expression in cancer datasets (Human Protein Atlas database [62]). (C) Representative histological staining of NUDT5 in tumour versus normal patient samples from colorectal, pancreatic, liver, breast and renal samples (Human Protein Atlas database [62]). Metadata regarding each of the images are given in Table S2 . Kaplan Meyer survival curves stratifying patients based on NUDT5 mRNA expression in (D) Kidney chromophobe (KICH). (E) Adrenalcorticocal carcinoma (ACC). (F) Liver hepatocellular carcinoma (LIHG) (G) Brain lower grade carcinoma (LGG) (H) Kidney renal clear cell carcinoma (KIRC) (I) Kidney renal papillary cell carcinoma (KIRP) were carried out using TGCA database with GEPIA interactive webserver [61]. (J) Recurrence and metastasis analysis in NUDT5 mRNA high expressing patient cohorts from BRCA dataset shown in Figure S1A . (K) Full western blot of NUDT5, PARP1 and FLAG protein levels in NUDT5 RES and NUDT5 KD cell clones.
. Analysis of the gene expression changes in 3D compared to 2D culture conditions. (A) PCA analysis of all RNA samples (Table S3 ) from T47D cells cultured in 2D and 3D conditions. (B) PCA analysis of RNA samples from T47D cells highlighted based on culture conditions. (C) Distribution of counts based on all samples (i) or highlighting samples rw_043_01_02_rnaseq (ii) and rw_044_01_02_rnaseq (iii). (D) GO-Biological process enrichment analysis showing the top 20 differentially expressed gene classes from 2D and 3D cultured cells. A full list of significant terms is given in Table S4 . (E) Reactome enrichment analysis of showing top 20 differentially expressed gene classes from 2D and 3D cultured cells. A full list of significant terms is given in Table S5 . (F) Kaplan Meyer survival curves stratifying patients based on SP1 expression in breast cancer and on ZNF281 (G) in cervical cancer.
Figure S3: Characterisation of the gene expression changes which dependent on NUDT5 in 3D cell culture.
(A) Representative images of oncospheres in T47D wt cells. (B) Relative mRNA expression of CAV1 in NUDT5 RES versus NUDT5 WT cells grown in 2D and 3D conditions (C) Full western blot showing protein expression levels of NUDT5 in NUDT5 res (WT) or NUDT5 KD (KD) cell lines grown in 2D or 3D (oncosphere) conditions. (D) Volcano plot showing the differential gene expression data in NUDT5 RES and NUDT5 KD cell lines cultured in 2D conditions. The position of NUDT5, PTGES, CAST, CITED and other genes named within the main body of text are shown. (E) Oncosphere number of NUDT RES cell lines grown in the presence or absence of doxycline; data are mean +/-SEM. (F) Representative images of NUDT RES cell lines grown in the presence of doxycline. (G) Representative images of oncospheres grown with HEK293T, BT474, U2OS and MNNG-HOS cell lines in the presence or absence of TH5427. Oncosphere area (H) and number (I) of NUDT5 RES versus NUDT5 TD cell lines; data are shown as mean +/-SEM.
Figure S4
: Model for the role of NUDT5 in tumour progression. Stratifying patients based on the expression levels of NUDT5 predicts a poorer prognosis based on the findings that NUDT5 activity is essential for key tumour drivers, including genes involved in CSC and EMT. This may enable more targeted selection of patients for drastic therapies.
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